Advertisement

Topics

Takeda's ulcerative colitis drug under FDA review

06:03 EDT 10 May 2019 | SmartBrief

Takeda Pharmaceutical's application for a subcutaneous formulation of Entyvio, or vedolizumab, has been accepted by the FDA f -More

Original Article: Takeda's ulcerative colitis drug under FDA review

NEXT ARTICLE

More From BioPortfolio on "Takeda's ulcerative colitis drug under FDA review"

Advertisement
Quick Search
Advertisement
Advertisement